1441379-82-3

Basic information

• Product Name: methyl 2-(3-(6-iodo-2,2-dimethyl-4-oxo-4H-[1,3]dioxino[5,4-f ]-benzofuran-7-yl)phenoxy)acetate
• Synonyms: methyl 2-(3-(6-iodo-2,2-dimethyl-4-oxo-4H-[1,3]dioxino[5,4-f ]-benzofuran-7-yl)phenoxy)acetate
• CAS NO: 1441379-82-3
• Molecular Weight: 508.266
• Mol File: 1441379-82-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 2-(3-(6-iodo-2,2-dimethyl-4-oxo-4H-[1,3]dioxino[5,4-f ]-benzofuran-7-yl)phenoxy)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-(3-(6-iodo-2,2-dimethyl-4-oxo-4H-[1,3]dioxino[5,4-f ]-benzofuran-7-yl)phenoxy)acetate(1441379-82-3)
• EPA Substance Registry System: methyl 2-(3-(6-iodo-2,2-dimethyl-4-oxo-4H-[1,3]dioxino[5,4-f ]-benzofuran-7-yl)phenoxy)acetate(1441379-82-3)

Safety Data

• Hazardous Substances Data: 1441379-82-3(Hazardous Substances Data)

Upstream product

• 89-86-1 4-hydroxysalicylic acid 
• 856106-63-3 2,4-dihydroxy-5-iodobenzoic acid 
• 1404435-50-2 7-hydroxy-6-iodo-2,2-dimethyl-4H-benzo[d][1,3]dioxin-4-one 
• 1404435-51-3 6-iodo-7-methoxy-2,2-dimethyl-4H-benzo[d][1,3]dioxin-4-one 
• 626-02-8 3-Iodophenol 
• 111758-60-2 methyl (3-iodophenoxy)acetate 
• 1441379-49-2 C₁₄H₁₈O₃Si 
• 474677-87-7 methyl 2-(3-ethynylphenoxy)acetate 
• 1441379-70-9 methyl 2-(3-((7-methoxy-2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)ethynyl)phenoxy)acetate 

Downstream Products

• 1404435-75-1 2-(3-(carboxymethoxy)phenyl)-3-((3-chlorophenyl)ethynyl)-6-hydroxybenzofuran-5-carboxylic acid 
• 1441379-94-7 methyl 2-(3-(6-((3-chlorophenyl)ethynyl)-2,2-dimethyl-4-oxo-4H-[1,3]dioxino[5,4-f ]benzofuran-7-yl)phenoxy)acetate 

Relevant articles and documents

A potent and selective small-molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseases

Lymphoid-specific tyrosine phosphatase (LYP), a member of the protein tyrosine phosphatase (PTP) family of signaling enzymes, is associated with a broad spectrum of autoimmune diseases. Herein we describe our structure-based lead optimization efforts with